Spectrum Pharmaceuticals, Inc. (SPPI)
Bought at 5.04. Analysts have it at 10. Down for a minor FDA issue. If it blows over, should be able to double the money in 24 months.
Tags: Spectrum Pharmaceuticals, SPPI
This entry was posted
on Monday, October 12th, 2009 at 11:36 pm and is filed under Investment Diary.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.